Calciject 40 Solution for Injection

Land: Bretland

Tungumál: enska

Heimild: VMD (Veterinary Medicines Directorate)

Virkt innihaldsefni:

Boric Acid, Calcium

Fáanlegur frá:

Norbrook Laboratories Limited

ATC númer:

amendedS

INN (Alþjóðlegt nafn):

Boric Acid, Calcium

Lyfjaform:

Solution for injection

Gerð lyfseðils:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

Meðferðarhópur:

Cattle

Lækningarsvæði:

Mineral

Leyfisstaða:

Authorized

Leyfisdagur:

1986-03-19

Vara einkenni

Revised: June 2010
ATCVet code amended
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Calciject 40 Solution For Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
_ACTIVE SUBSTANCE:_
Each 400ml contains:-
11.88g Calcium provided by Calcium Gluconate and Calcium
Borogluconate.
Also contains 6.5% w/v Boric Acid.
For a full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Solution for Injection
A clear, pale, yellow solution
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of hypocalcaemia in cattle
4.3
CONTRAINDICATIONS
None
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
The solution should be warmed to body temperature before
administration. Intravenous injections should be given slowly.
Observe aseptic precautions
Revised: June 2010
ATCVet code amended
Page 2 of 4
ii.
Special precautions to be taken by the person administering the
veterinary medicinal product to animals
Care should be taken to avoid accidental self-injection: may cause
irritation at site of injection.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Provided the recommendations are followed carefully, undesirable
effects
should not occur.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
Calciject 40 can be safely administered to pregnant and lactating
animals.
4.8
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
No known interactions.
4.9
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Administer by subcutaneous or slow intravenous injection at the
following
rate:
Cattle :
150 - 500 ml
4.10
OVERDOSE (SYMPTOMS, EMERGENCY PROCEDURES, ANTIDOTES), IF NECESSARY
Not applicable.
4.11
WITHDRAWAL PERIOD
Meat
:
Zero days
Milk
:
Zero hours
5.
PHARMACOLOGICAL PROPERTIES
PHARMACOTHERAPEUTIC GROUP: Mineral supplements, Calcium
ATC VET CODE: QA12AA
5.1
PHARMACODYNAMIC PROPERTIES
Milk fever which is characterised by hypocalcaemia is ca